Protgen Ltd

Industry · 13 registered clinical trials.

Status	Trial	Phase	Started
Completed	Phase II/III Clinical Trial of Recombinant Human Serum Albumin in Cirrhotic Patients With Ascites Cirrhotic Ascites	Phase 2 / Phase 3	2024-08-19
Active Not Recruiting	Recombinant Human Serum Albumin in the Treatment of AD (Alzheimer Disease) Exploratory Clinical Trials Alzheimer's Disease (AD)	EARLY_Phase 1	2024-06-28
Completed	Phase II/III of Recombinant Human Serum Albumin Cirrhotic Ascites	Phase 2 / Phase 3	2023-05-24
Completed	Recombinant Human Serum Albumin in Patients With Liver Cirrhosis and Ascites Subjects Hepatic Ascites	Phase 1	2021-10-14
Completed	Recombinant Human Serum Albumin in Healthy Subjects Hepatic Ascites	Phase 1	2021-03-29
Unknown	Clinical Trial of Quantitative Detection Kit for Hsp90α in Breast Cancer Breast Cancer	N/A	2013-04-01
Unknown	Clinical Trial of Quantitative Detection Kit for Hsp90α in Hepatic Cancer Liver Cancer	N/A	2012-10-01
Unknown	Clinical Trial of Quantitative Detection Kit for Hsp90α in Colorectal Cancer Colorectal Cancer	N/A	2012-09-01
Unknown	Paclitaxel-Carboplatin Alone or With M2ES for Non-Small-Cell Lung Cancer Non Small Cell Lung Cancer	Phase 2	2011-05-01
Unknown	Study of M2ES in Patients With Advanced Pancreatic Cancer After Gemcitabine Treatment Failure Pancreatic Cancer	Phase 1	2010-08-01
Unknown	Study With M2ES and Gemcitabine for Patients With Advanced Pancreatic Cancer Pancreatic Cancer	Phase 1	2010-06-01
Unknown	Dose Escalation and PK Study of M2ES in Subjects With Advanced Solid Tumors Advanced Solid Tumors	Phase 1	2009-09-01
Completed	Single-dose Escalation Trial of M2ES in Healthy Volunteer Cancer	Phase 1	2009-05-01